Last Close
17.00 $
Jul 6, 26
Market Cap
871.7 M $
Q1 2026 (TTM)
52-Week Range
%+50.3
%46.6
0.27
0.25
%-18.0
-%34.6
1M
+4.4%
3M
+5.6%
6M
-7.7%
YTD
-9.1%
1Y
+52.5%
3Y
+66.5%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
TBPH last closed at 17.00 $ (Jul 6, 26). Price data is refreshed after every trading day.
Theravance Biopharma Inc trades at a trailing-twelve-month P/E of 7.61. See the comparison tables on the Peers tab for the industry context.
Theravance Biopharma Inc (TBPH) has a market capitalization of approximately 871.7 M $ as of the latest reported period.
Key peers of Theravance Biopharma Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., CSL Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.